---
category: news
title: "Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital"
abstract: "About PROGENICSProgenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and RELISTOR(R) (methylnaltrexone bromide ..."
publishedDateTime: 2019-06-28T01:00:00Z
sourceUrl: https://www.marketwatch.com/press-release/progenics-pharmaceuticals-details-recent-good-faith-efforts-to-settle-with-velan-capital-2019-06-27-21184057
type: article

provider:
  name: MarketWatch
  id: marketwatch

topics:
 - AI
 - artificial intelligence therapy
 - AI in Healthcare
---
